Investment analysts at StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
RKDA stock opened at $4.85 on Monday. The stock has a 50-day simple moving average of $5.24 and a 200-day simple moving average of $3.85. The firm has a market cap of $6.60 million, a P/E ratio of -1.13 and a beta of 0.88. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31.
About Arcadia Biosciences
Read More
- Five stocks we like better than Arcadia Biosciences
- With Risk Tolerance, One Size Does Not Fit All
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- The How and Why of Investing in Gold Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.